Garofalo Health Care S.p.A. (BIT:GHC)
Italy · Delayed Price · Currency is EUR 5.24
+0.09 (1.75%)
At close: Nov 19, 2025
Garofalo Health Care Revenue
Garofalo Health Care had revenue of 105.84M EUR in the quarter ending September 30, 2025, with 9.11% growth. This brings the company's revenue in the last twelve months to 483.61M, up 7.39% year-over-year. In the year 2024, Garofalo Health Care had annual revenue of 467.77M with 27.76% growth.
Revenue (ttm)
483.61M
Revenue Growth
+7.39%
P/S Ratio
0.94
Revenue / Employee
168.80K
Employees
2,708
Market Cap
454.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 467.77M | 101.63M | 27.76% |
| Dec 31, 2023 | 366.14M | 46.10M | 14.40% |
| Dec 31, 2022 | 320.04M | 37.12M | 13.12% |
| Dec 31, 2021 | 282.93M | 74.59M | 35.80% |
| Dec 31, 2020 | 208.34M | 13.98M | 7.19% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.55B |
| Amplifon | 2.41B |
| DiaSorin | 1.21B |
| Safilo Group | 998.89M |
| EL.En. | 579.71M |
| GPI S.p.A. | 531.42M |
| Svas Biosana | 134.95M |
| Talea Group | 132.17M |